Krystal Eckhart was appointed as Interim CEO and CFO at SELECTIS HEALTH, INC..
“On May 15, 2026, the Board of Directors of the Company appointed Krystal Eckhart to serve as the Company’s Interim CEO and CFO.”
SELECTIS HEALTH, INC. — fact timeline
Source-grounded facts extracted from SELECTIS HEALTH, INC.'s SEC 8-K filings across all families, newest first. Each cites a verbatim SEC excerpt.
Adam Desmond resigned as CEO, CFO and Director at SELECTIS HEALTH, INC..
“Effective May 14, 2026 the Board of Directors of Selectis Health, Inc., a Utah corporation (the “Company”) and Adam Desmond (“Desmond”) agreed that he would resign all positions with the Company including CEO, CFO of the Company and a member of the Board of Directors.”
SELECTIS HEALTH, INC. completed a disposition involving GA SNF ABBEVILLE GA LLC and GA SNF EASTMAN GA LLC for $15.7 million aggregate purchase price, subject to prorations, holdbacks and adjustments; net proceeds approximately $9 million excluding $1.57 million escrows (closed 2026-05-01).
“Facility” and together with the Sparta Facility, the “Facilities”). The purchase price to be paid by Purchaser for the two (2) Facilities under the PSA. was an aggregate of $15.7 million, subject to certain prorations, holdbacks and adjustments customary in transactions of this nature. Net proceeds received at closing, after payment of mortgage debt and other”
SELECTIS HEALTH, INC. entered into Operations Transfer Agreement with Abbeville Crossing of Journey LLC and Eastman Trails of Journey LLC (effective 2026-03-05).
“Concurrently with the execution of the PSA, the Company caused the Existing Operators to execute an Operations Transfer Agreement (“ OTA ”) with two newly formed entities affiliated with the Purchasers, Abbeville Crossing of Journey LLC and Eastman Trails of Journey LLC, each a Georgia limited liability company (each a “ New Operator ”)”
SELECTIS HEALTH, INC. entered into Purchase and Sale Agreement with Abbeville Crossing Propco of Journey LLC and Eastman Trails Propco of Journey LLC valued at $15,700,000.00 (effective 2026-03-05).
“Effective on March 5, 2026, Selectis Health, Inc., a Utah corporation (the “ Company ”) caused two of the Company’s wholly-owned subsidiaries Global Abbeville Property, LLC and Dodge NH, LLC , each a Georgia limited liability company (each a “ Seller ”) to execute and deliver a definitive Purchase and Sale Agreement (“ PSA ”) with two newly formed entities: Abbeville Crossing Propco of Journey LLC and Eastman Trails Propco of Journey LLC, each a Georgia limited liability company (each a “ Purchaser ”)”
SELECTIS HEALTH, INC. completed a disposition involving GA SNF SPARTA GA LLC and GA SNF WARRENTON GA LLC for $13.175 million (closed 2026-01-15).
“Facility” and together with the Sparta Facility, the “Facilities”). The purchase price to be paid by Purchaser for the two (2) Facilities under the PSA. was an aggregate of $13.175 million, subject to certain prorations, holdbacks and adjustments customary in transactions of this nature. The Purchaser had a balance of $1.3 million of escrow established at closing,”
SELECTIS HEALTH, INC. issued convertible note.
“Effective December 31, 2025, the Company entered into a Third Amended and Restated Allonge and Modification Agreement (the “Third Allonge”) with the holders of more than a majority in interest in the Company’s 2018 11% Senior Secured Promissory Notes (the “Notes”).”
SELECTIS HEALTH, INC. entered into Operations Transfer Agreement with The Woods at Sparta of Journey LLC, and Warrenton Woods of Journey LLC (effective 2025-12-05).
“Concurrently with the execution of the PSA, the Company caused the Existing Operators to execute an Operations Transfer Agreement (“ OTA ”) with two newly formed entities affiliated with the Purchasers, The Woods at Sparta of Journey LLC, and Warrenton Woods of Journey LLC, each a Georgia limited liability company (each a “ New Operator ”)”
SELECTIS HEALTH, INC. entered into Purchase and Sale Agreement with The Woods at Sparta of Journey Propco LLC and Warrenton Woods of Jour Propco LLC valued at $13,175,000.00 (effective 2025-12-05).
“Effective on December 5, 2025, Selectis Health, Inc., a Utah corporation (the “ Company ”) caused two of the Company’s wholly-owned subsidiaries Providence HR, LLC and Atl/Warr, LLC , each a Georgia limited liability company (each a “ Seller ”) to execute and deliver a definitive Purchase and Sale Agreement (“ PSA ”) with two newly formed entities: The Woods at Sparta of Journey Propco LLC and Warrenton Woods of Jour Propco LLC, each a Georgia limited liability company (each a “ Purchaser ”)”
Adam Desmond was appointed as Chief Financial Officer at SELECTIS HEALTH, INC..
“Adam Desmond, the Company’s current CEO, will serve as the Interim CFO until a permanent CFO is identified.”
James Creamer resigned as Chief Financial Officer at SELECTIS HEALTH, INC..
“On January 17, 2025, James Creamer tendered his resignation as Chief Financial Officer of Selectis Health, Inc. (the “Company”), pursuant to a Separation Agreement and Release of even date.”
SELECTIS HEALTH, INC. engaged WithumSmith+Brown, PC as its auditor.
“Effective December 4, 2024, the Company’s Board of Directors, at the recommendation of the Audit Committee that has been separately appointed, approved the appointment of WithumSmith+Brown, PC (“Withum”) to serve as the Company’s independent registered public accounting firm.”
James Creamer was appointed as Chief Financial Officer at SELECTIS HEALTH, INC..
“On August 27, 2024 the Board of Directors of Selectis Health, Inc., a Utah corporation (the “Company”) approved the appointment of James Creamer to the position of Chief Financial Officer, effective August 15, 2024.”
Andrew Sink resigned as member of the Board of Directors at SELECTIS HEALTH, INC..
“On June 24, 2024, Andrew Sink tendered his resignation as a member of the of the Selectis Health, Inc. (the “Company”) Board of Directors, effective June 30, 2024.”
SELECTIS HEALTH, INC. completed a disposition involving Bibb County Holdings II, LLC for $6.75 million (closed 2024-06-18).
“with the original Purchase and Sale Agreement (the “PSA”) executed on May 1, 2024, Bibb County Holdings II, LLC (the “Purchaser”) has purchased the Archway Property for $6.75 million. The sale was completed on June 18, 2024. A copy of the PSA was previously filed as an exhibit to the Company’s Current Report on Form 8-K dated May 1, 2024 and filed with”
SELECTIS HEALTH, INC. entered into Purchase and Sale Agreement with Bibb County Holdings II, LLC valued at Six Million Seven Hundred Fifty Thousand Dollars ($6,750,000) (effective 2024-05-01).
“On May 1, 2024, Selectis Health, Inc., a Utah corporation (the “ Company ”) caused its wholly-owned subsidiary Goodwill Hunting, LLC, a Georgia limited liability company (“ Seller ”) to execute and deliver a definitive Purchase and Sale Agreement (“ PSA ”) with Bibb County Holdings II, LLC, a Georgia limited liability company (“ Purchaser ”); pursuant to which the Seller agreed to sell certain real property located in Macon, Bibb County, Georgia identified as Bibb County Tax Parcels P1030040, P1030254, P1030253, P1030043, P1030052, and P1030252 including that certain skilled nursing facility known as “Archway Transitional Care Center” located at 4373 Houston Avenue, Macon, Bibb County, 31206 (the “Archway Property”).”
SELECTIS HEALTH, INC. incurred credit facility of $750,000 with Southern Bank at 8.50% per annum maturing April 12, 2025.
“On April 12, 2024, Selectis Health, Inc., a Utah corporation (the "Company") entered into a Commercial Line of Credit Agreement and Note with Southern Bank for a line of credit in the principal amount limit of $750,000 at a fixed interest rate of 8.50% per annum with a Maturity Date of April 12, 2025.”
Adam Desmond was appointed as Chief Executive Officer at SELECTIS HEALTH, INC..
“Effective March 18, 2024, the Board of Directors of Selectis Health, Inc., a Utah corporation (the “Company”) appointed Adam Desmond to the position of Chief Executive Officer.”
SELECTIS HEALTH, INC. terminated Purchase and Sale Agreement and Operations Transfer Agreement with Purchaser valued at Termination of the PSA and OTA without consummation (effective 2024-02-20).
“Effective February 20, 2024, Selectis Health, Inc., a Utah corporation (the “ Company ”) received written notice from the Purchaser (“ Purchaser ”) under the Purchase and Sale Agreement (“ PSA ”) and Operations Transfer Agreement (“ OTA ”) for the sale of certain of its Georgia subsidiaries, as previously reported on its Current Report on Form 8-K dated November 30, 2023 and filed with the Securities and Exchange Commission on December 5, 2023, that the Purchaser was terminating the PSA and OTA without consummation.”
Clifford Neuman was appointed as director at SELECTIS HEALTH, INC..
“On December 18, 2023, Selectis Health, Inc., a Utah corporation (the “Company”) appointed Jim Creamer as Interim Chief Financial Officer and Clifford Neuman to its board of directors.”
Jim Creamer was appointed as Interim Chief Financial Officer at SELECTIS HEALTH, INC..
“On December 18, 2023, Selectis Health, Inc., a Utah corporation (the “Company”) appointed Jim Creamer as Interim Chief Financial Officer and Clifford Neuman to its board of directors.”
SELECTIS HEALTH, INC. entered into Operations Transfer Agreement with Glen Eagle Nursing and Rehabilitation LLC, Eastman Nursing and Rehabilitation LLC, Providence Nursing and Rehabilitation LLC, Warrenton Nursing and Rehabilitation LLC valued at Governs transfer of skilled nursing operations from Existing Operators to New Operators, contingent (effective 2023-11-30).
“Concurrently with the execution of the PSA, the Company caused the Existing Operators to execute an Operations Transfer Agreement (“ OTA ”) with four newly formed entities affiliated with the Purchasers, Glen Eagle Nursing and Rehabilitation LLC, Eastman Nursing and Rehabilitation LLC, Providence Nursing and Rehabilitation LLC and Warrenton Nursing and Rehabilitation LLC, each a Nevada limited liability company (each a “ New Operator ”).”
SELECTIS HEALTH, INC. entered into Purchase and Sale Agreement with Glen Eagle Propco LLC, Eastman Propco LLC, Providence Propco LLC, Warrenton Propco LLC valued at Purchase price $31.0 million for four skilled nursing facilities (effective 2023-11-30).
“ENTRY INTO DEFINITIVE MATERIAL AGREEMENTS Purchase and Sale Agreement Effective on November 30, 2023, Selectis Health, a Utah corporation (the “ Company ”) caused four of the Company’s wholly-owned subsidiaries Global Abbeville Property, LLC, Dodge NH, LLC, Providence HR, LLC and ATL/WARR, LLC, each a Georgia limited liability company (each a “ Seller ”), to execute and deliver a definitive Purchase and Sale Agreement (“ PSA ”) with four newly formed entities: Glen Eagle Propco LLC, Eastman Propco LLC, Providence Propco LLC and Warrenton Propco LLC, each a Delaware limited liability company (each a “ Purchaser ”), pursuant to which each Seller agreed to sell substantially all of the real and personal property owned by each, namely the skilled nursing facilities located at 206 Main Street East, Abbeville, Georgia, 31001, upon which is located that certain 101-bed skilled nursing facility commonly known as “Glen Eagle Healthcare & Rehab” (the “ Glen Eagle Facility ”), 556 Chester Highway”
Adam Desmond was appointed as Interim Chief Executive Officer at SELECTIS HEALTH, INC..
“Adam Desmond, a current Board member, has agreed to be appointed Interim Chief Executive Officer.”
Lance J. Baller resigned as Chief Executive Officer at SELECTIS HEALTH, INC..
“On October 31, 2023, Lance J. Baller tendered his resignation from all positions with the Company, including as Chief Executive Officer, acting principal financial officer and a member of the Board of Directors of Selectis Health, Inc. (the “Company”), effective November 13, 2023 or at such earlier date as the Company finds a replacement.”
Christopher "Randy" Barker resigned as President, Chief Operating Officer at SELECTIS HEALTH, INC..
“On May 27, 2023, Christopher “Randy” Barker tendered his resignation as President, Chief Operating Officer and a member of the Board of Directors of Selectis Health, Inc. (the “Company”), effective May 31, 2023.”
Lance Baller was appointed as principal financial officer at SELECTIS HEALTH, INC..
“Lance Baller, our current CEO, will serve as the Company’s principal financial officer until we identify a permanent CFO.”
Christine Lucus resigned as Chief Financial Officer at SELECTIS HEALTH, INC..
“On March 6, 2023, Christine Lucus tendered her resignation as Chief Financial Officer of Selectis Health, Inc. (the “Company”), effective April 5, 2023.”
SELECTIS HEALTH, INC. shareholders approved Ratification of the selection of Marcum LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2022 at the 2022-12-07 meeting.
“At the Meeting, the vote to ratify the selection of Marcum LLP as the Company’s independent registered public accounting firm for the current fiscal year ending December 31, 2022, was as follows: FOR AGAINST ABSTAIN 1,514,159 6,725 114”
SELECTIS HEALTH, INC. shareholders approved Election of one Class I Director to serve for a term of three years and until the election and qualification of his successor in office at the 2022-12-07 meeting.
“At the Meeting, the vote to elect one (1) Class I Director to serve for a term of three years and until the election and qualification of his successor in office, was as follows: FOR WITHHELD BROKER NON-VOTE Andy Sink 1,270,541 41,080 209,377”
Clifford Neuman departed as Secretary at SELECTIS HEALTH, INC..
“Ms. Lucus will replace Clifford Neuman as the Company’s Secretary”
Mary Christine Lucus was appointed as Secretary at SELECTIS HEALTH, INC..
“has appointed Mary Christine Lucus to serve as the Company’s Secretary”
Andrew Sink was appointed as Class I director at SELECTIS HEALTH, INC..
“Effective October 17, 2022 the Board of Directors of the Company approved the appointment of Mr. Andrew Sink to serve as a Class I member of the Board of Directors of Company to fill the vacancy created by the resignation of Mr. Neuman.”
Clifford Neuman resigned as director and secretary at SELECTIS HEALTH, INC..
“Effective October 17, 2022, Clifford Neuman resigned as a director and secretary of Selectis Health, Inc. (the “Company”).”
David J. Furstenberg was appointed as Director at SELECTIS HEALTH, INC..
“approved the appointment of Mr. David J. Furstenberg to serve as a member of the Board of Directors of Company.”
Christine Lucus was appointed as interim Chief Financial Officer at SELECTIS HEALTH, INC..
“Christine Lucus, formerly serving as Controller, has been appointed interim CFO of the Company effective March 4, 2022.”
Brandon Thall resigned as Chief Financial Officer at SELECTIS HEALTH, INC..
“Mr. Brandon Thall tendered his resignation as Chief Financial Officer of Selectis Health, Inc.”
Facts are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.